Literature DB >> 7544016

Mechanisms of viral inhibition by interferons.

S Landolfo1, G Gribaudo, A Angeretti, M Gariglio.   

Abstract

Interferons (IFNs) are a family of related proteins grouped in four species (alpha, beta, gamma and omega) according to their cellular origin, inducing agents and antigenic and functional properties. Their binding to specific receptors leads to the activation of signal transduction pathways that stimulate a defined set of genes, whose products are eventually responsible for the IFN antiviral effects. Their action against viruses is a complex phenomenon. It has been reported that IFNs restrict virus growth at the levels of penetration, uncoating, synthesis of mRNA, protein synthesis and assembly. This review will attempt to evaluate evidence of the involvement of the IFN-inducible proteins in the expression of the antiviral state against RNA or DNA viruses.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544016     DOI: 10.1016/0163-7258(95)98599-l

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  10 in total

1.  Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated.

Authors:  Julia S Pettersen; Judilyn Fuentes-Duculan; Mayte Suárez-Fariñas; Katherine C Pierson; Alexander Pitts-Kiefer; Linda Fan; Daniel A Belkin; Claire Q F Wang; Shivaprasad Bhuvanendran; Leanne M Johnson-Huang; Mark J Bluth; James G Krueger; Michelle A Lowes; John A Carucci
Journal:  J Invest Dermatol       Date:  2011-02-10       Impact factor: 8.551

2.  Possible involvement of the double-stranded RNA-binding core protein sigmaA in the resistance of avian reovirus to interferon.

Authors:  J Martínez-Costas; C González-López; V N Vakharia; J Benavente
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Functional IFNG polymorphism in intron 1 in association with an increased risk to promote sporadic breast cancer.

Authors:  Anjana Saha; Ashish Dhir; Anand Ranjan; Vibhuti Gupta; Narendra Bairwa; Ramesh Bamezai
Journal:  Immunogenetics       Date:  2005-03-09       Impact factor: 2.846

4.  Role of the individual interferon systems and specific immunity in mice in controlling systemic dissemination of attenuated pseudorabies virus infection.

Authors:  P Grob; V E Schijns; M F van den Broek; S P Cox; M Ackermann; M Suter
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

5.  Polymorphism in the interferon-alpha gene family.

Authors:  I Golovleva; M Kandefer-Szerszen; L Beckman; E Lundgren
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

6.  Reversible inhibition of murine cytomegalovirus replication by gamma interferon (IFN-γ) in primary macrophages involves a primed type I IFN-signaling subnetwork for full establishment of an immediate-early antiviral state.

Authors:  Kai A Kropp; Kevin A Robertson; Garwin Sing; Sara Rodriguez-Martin; Mathieu Blanc; Paul Lacaze; Muhamad F B Noor Hassim; Mizanur R Khondoker; Andreas Busche; Paul Dickinson; Thorsten Forster; Birgit Strobl; Mathias Mueller; Stipan Jonjic; Ana Angulo; Peter Ghazal
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

7.  Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis.

Authors:  Vanessa S Cull; Emmalene J Bartlett; Cassandra M James
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

8.  Both viral and host factors contribute to neurovirulence of bovine herpesviruses 1 and 5 in interferon receptor-deficient mice.

Authors:  Carlos Abril; Monika Engels; Anne Liman; Monika Hilbe; Sarah Albini; Marco Franchini; Mark Suter; Mathias Ackermann
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

9.  Novel cell type-specific antiviral mechanism of interferon gamma action in macrophages.

Authors:  R M Presti; D L Popkin; M Connick; S Paetzold; H W Virgin
Journal:  J Exp Med       Date:  2001-02-19       Impact factor: 14.307

10.  A temporal gate for viral enhancers to co-opt Toll-like-receptor transcriptional activation pathways upon acute infection.

Authors:  Kai A Kropp; Wei Yuan Hsieh; Elena Isern; Thorsten Forster; Eva Krause; Wolfram Brune; Ana Angulo; Peter Ghazal
Journal:  PLoS Pathog       Date:  2015-04-09       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.